Dynogen Pharmaceuticals: Clinical Trials

4 trials sponsored by Dynogen Pharmaceuticals, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 1 terminated, 1 unknown. 4 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 24Completed 2, Terminated 1, Unknown 1
Phase 31Unknown 1

Follow Dynogen Pharmaceuticals: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females
DDP733 - Irritable Bowel Syndrome
Phase 2 / Phase 3UnknownDynogen Pharmaceuticals3602007-10-012008-04-08
12 Weeks Treatment With DDP225 or Placebo in Patients With Chronic Functional Vomiting
DDP225 - Vomiting
Phase 2TerminatedDynogen Pharmaceuticals302005-11-012007-10-12
8 Weeks Treatment With DDP225 in Patients With Diarrhea Predominant IBS
DDP225 - Irritable Bowel Syndrome
Phase 2CompletedDynogen Pharmaceuticals882005-09-012007-10-15
A Study to Evaluate the Safety, Tolerability and Pharmacodynamics of DDP733 for IBS-c
DDP733 - Irritable Bowel Syndrome With Constipation, Irritable Bowel Syndrome
Phase 2CompletedDynogen Pharmaceuticals902005-09-012007-05-28

Conditions studied

Irritable Bowel Syndrome (3)  ·  Ichthyosis Bullosa of Siemens (1)  ·  Nausea (1)  ·  Vomiting (1)

Interventions

DDP733 (2)

Countries

Canada (3)  ·  United States (3)

Top investigators

Ray Clouse, MD (1)  ·  William Paterson, MD (1)  ·  William Patterson, MD (1)